Try our Advanced Search for more refined results
Searching dockets in Medical Components Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent | Utah
In Limine
Defendant's MOTION in Limine to Adopt and Preclude Relitigation of Federal Circuit Holding That Power Injectable Ports Having Radiopaque Features Were State of the Art Prior to 2004 filed by Counter Claimant Medical Components, Defendant Medical Components. (Attachments: # 1 Exhibit A- US8475417, # 2 Exhibit B- US8545460, # 3 Exhibit C- US8805478, # 4 Exhibit D- US7785302, # 5 Exhibit E- US7947022, # 6 Exhibit F- US7959615)(Berger, Arthur)
Response to Motion
RESPONSE to Motion re 1022 Redacted MOTION in Limine Seeking Enforcement of the Courts July 10th Orders filed by Counter Claimant Medical Components, Defendant Medical Components. (Attachments: # 1 Exhibit A- Roman Report, # 2 Exhibit B- Redacted Roman Report, # 3 Exhibit C- Bard Version Roman Report, # 4 Exhibit D- Redacted Kiani Report, # 5 Exhibit E- Redacted Shoenfeld Report, # 6 Exhibit F- Wholey Report, # 7 Exhibit G- Shapiro Report, # 8 Exhibit H- Redacted Hricik Report)(Berger, Arthur)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.